ADDvise receives order from AstraZeneca in China worth 2.2 MSEK.

ADDvise has received an order from AstraZeneca in Wuxi, China, to deliver laboratory furnishings and safety ventilation to a chemistry laboratory and a microbiology laboratory. The order amounts to 2.2 MSEK and will be delivered during 2015. The order will be delivered to AstraZeneca's research and development laboratory in Wuxi.

- This is the second order in China in a short time. It is exciting to see that the interest in ADDvise solutions is growing on the gigantic Chinese market. We see great potential for future growth in China, where infrastructure investments is constantly increasing in line with increased economic prosperity and increased life expectancy, says Rikard Akhtarzand CEO of ADDvise, in a comment on today's order.


For further information, please contact:

Rikard Akhtarzand, CEO, +46 765-25 90 71


About ADDvise Lab Solutions AB

ADDvise Lab Solutions AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical Tables Inc. offers comprehensive solutions in the form of products and services to healthcare and research facilities. ADDvise Group's customers are located in both the private and public sectors. The Company's share is listed on First North Premier and Mangold Fondkommission AB, +46 8-503015 50, is the company's Certified Adviser and liquidity provider.

About Us

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier. Additional information is available at